Previous Close | 23.11 |
Open | 22.86 |
Bid | 22.77 x 100 |
Ask | 22.92 x 100 |
Day's Range | 22.80 - 22.90 |
52 Week Range | 21.90 - 32.89 |
Volume | |
Avg. Volume | 847,359 |
Market Cap | 14.516B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | 21.98 |
EPS (TTM) | 1.04 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 38.90 |
In a week marked by intense economic and earnings activity, global markets experienced varied performances with the technology-heavy Nasdaq Composite and S&P MidCap 400 Index hitting record highs before pulling back, while small-cap stocks showed resilience compared to their larger counterparts. As growth stocks lagged behind value shares amid cautious earnings reports from major tech players, identifying promising high-growth tech stocks requires careful consideration of fundamentals such as...
Genmab AS (GMAB) reports a 29% revenue increase and strategic moves in its product pipeline, despite challenges in early-stage programs.